@J_Cardiol profile picture
Journal of Cardiology @J_Cardiol

Journal of Cardiology #JCardiol is Official Journal of Japanese College of Cardiology〔日本心臓病学会〕and peer-reviewed cardiovascular journal. 2024 IF is 2.6 !!!

Joined April 2021
  • Tweets 5,076
  • Following 1,191
  • Followers 1,802
638 Photos and videos
Pinned Tweet
Journal of Cardiology@J_Cardiol
10 Aug 2025
<<<NEWS>>> Our 2024 impact factor is 2.6 !!! Please submit your papers to @J_Cardiol #JCardiol journal-of-cardiology.com/ by A.E. K
3
8
2,739
#JCardiol 87(5): 477-8, 2026 ⭐️Letter to the Editors Author's reply: An evidence-based tool for screening for heart failure with preserved ejection fraction in primary care: The BREATH2 score: Discussion from a statistical... Saito Y, Obokata M doi.org/10.1016/j.jjcc.2026.… by A.E. K
1
120
#JCardiol 87(5): 475-6, 2026 ⭐️Letter to the Editors Author's reply to the Letter to the Editor regarding “Characteristics of histologically proven fulminant myocarditis managed with venoarterial extracorporeal membrane... Noguchi T et al doi.org/10.1016/j.jjcc.2025.… by A.E. K
106
#JCardiol 87(5): 473-4, 2026 ⭐️Letter to the Editors Author's reply: Comparing BREATH2 with HFA-PEFF and H2FPEF: Room for integration or redundancy? Saito Y, Obokata M doi.org/10.1016/j.jjcc.2026.… by A.E. K
1
109
#JCardiol 87(5): 473, 2026 ⭐️Letter to the Editors Comparing BREATH2 with HFA-PEFF and H2FPEF: Room for integration or redundancy? Muhammad Mohid Haroon doi.org/10.1016/j.jjcc.2025.… by A.E. K
82
#JCardiol 87(5): 471-2, 2026 ☑️Research Letter Contemporary clinical characteristics, management strategies, and outcomes of fluoropyrimidine-induced angina – A descriptive study Ziad Zalaquett et al doi.org/10.1016/j.jjcc.2025.… by A.E. K
3
258
#JCardiol 87(5): 471-2, 2026 Contemporary clinical characteristics, management strategies... Highlights 3/3 ☑️Wide management variability in our cohort highlights need for standardized protocols doi.org/10.1016/j.jjcc.2025.… by A.E. K
81
#JCardiol 87(5): 471-2, 2026 Contemporary clinical characteristics, management strategies... Highlights 2/3 ☑️No clinical or treatment-related predictors of recurrence were identified. doi.org/10.1016/j.jjcc.2025.… by A.E. K
53
#JCardiol 87(5): 471-2, 2026 Contemporary clinical characteristics... Highlights 1/3 ☑️Fluoropyrimidine-induced angina occurred early in treatment for most patients. ☑️Rechallenge was common, but angina recurred in 36 % of patients. doi.org/10.1016/j.jjcc.2025.… by A.E. K
96
#JCardiol 87(5): 468-70, 2026 ☑️Research Letter Beta-blocker therapy for acute myocardial infarction with preserved ejection fraction: A meta-analysis from randomized controlled trials Hiruma Y et al doi.org/10.1016/j.jjcc.2026.… by A.E. K
3
423
#JCardiol 87(5): 468-70, 2026 Beta-blocker therapy for acute myocardial infarction with preserved ejection fraction: A meta-analysis from Highlights 3/3 ☑️Further data regarding MI etiology is warranted for exploring better indications. doi.org/10.1016/j.jjcc.2026.… by A.E. K
125
#JCardiol 87(5): 468-70, 2026 Beta-blocker therapy for acute myocardial infarction with preserved ejection fraction: A meta-analysis from randomized Highlights 2/3 ☑️Beta-blocker and non-beta-blocker therapy showed comparable safety risks. doi.org/10.1016/j.jjcc.2026.… by A.E. K
174
#JCardiol 87(5): 468-70, 2026 Beta-blocker therapy for acute myocardial infarction with preserved ejection fraction: A meta-analysis from... Highlights 1/3 ☑️Beta-blockers were not linked to lower cardiac risks in AMI with preserved LVEF. doi.org/10.1016/j.jjcc.2026.… by A.E. K
97
#JCardiol 87(5): 459-67, 2026 ✅Review Therapeutic ultrasound for acute myocardial infarction: Mechanisms, preclinical evidence, and clinical perspectives Katayama Y et al doi.org/10.1016/j.jjcc.2026.… by A.E. K
3
1
1
336
#JCardiol 87(5): 459-67, 2026 Therapeutic ultrasound for acute myocardial infarction... Highlights 3/3 ☑️Emerging 3D and pre-hospital applications may further improve outcomes. doi.org/10.1016/j.jjcc.2026.… by A.E. K
215
#JCardiol 87(5): 459-67, 2026 Therapeutic ultrasound for acute... Highlights 2/3 ☑️Preclinical studies show improved recanalization and reduced infarct size. ☑️Clinical trials highlight pre-PCI sonotherapy as key for myocardial salvage. doi.org/10.1016/j.jjcc.2026.… by A.E. K
45
#JCardiol 87(5): 459-67, 2026 Therapeutic ultrasound... Highlights 1/3 ☑️Ultrasound–microbubble therapy enhances reperfusion in acute myocardial infarction. ☑️Sonothrombolysis dissolves thrombi, while sonoperfusion restores microvascular flow. doi.org/10.1016/j.jjcc.2026.… by A.E. K
52
#JCardiol 87(5): 451-8, 2026 ✅Topics Physiological impact of lipid-rich plaque on coronary microvascular dysfunction: Evaluation using near-infrared spectroscopy intravascular ultrasound and angiography-derived index... Yamada N et al doi.org/10.1016/j.jjcc.2025.… by A.E. K
3
2
3
1,419
#JCardiol 87(5): 451-8, 2026 Physiological impact of lipid-rich plaque on coronary microvascular dysfunction... Highlights 3/3 ☑️The incidence of CMD increased stepwise when both indices exceeded the cut-offs. doi.org/10.1016/j.jjcc.2025.… by A.E. K
1
2
1,493
#JCardiol 87(5): 451-8, 2026 Physiological impact of lipid-rich plaque on coronary microvascular dysfunction... Highlights 2/3 ☑️Both metrics showed a stepwise trend between lipid burden and microvascular dysfunction. doi.org/10.1016/j.jjcc.2025.… by A.E. K
1
1
1,602
#JCardiol 87(5): 451-8, 2026 Physiological impact of lipid-rich plaque on coronary... Highlights 1/3 ☑️Pre-PCI maxLCBI4mm ≥ 579 independently predicted CMD after PCI. ☑️LBS ≥20,384 was also an independent predictor of post-PCI CMD. doi.org/10.1016/j.jjcc.2025.… by A.E. K
1
1
1,110
Load more